BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan

  August 13, 2025

   · 

  1 min read
• Press Releases

  Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

  August 13, 2025

   · 

  4 min read
• Press Releases

  Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Conce

  - Funding combines equity investment and convertible loan - Focus on best-in-class, clinical-stage peanut allergen neutralizing antibody - Further potential for developing Mabylon’s discovery and pre-clinical pipeline programs - Dr. Thomas Hecht has joined Board of Directors

  August 13, 2025

   · 

  1 min read
• Press Releases

  Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

  August 13, 2025

   · 

  5 min read
• Press Releases

  Corza Medical Launches Biomedical Textiles Innovation Lab to Accelerate OEM Product Development

  August 13, 2025

   · 

  3 min read
• Press Releases

  Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

  August 13, 2025

   · 

  5 min read
• Press Releases

  Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease

  August 13, 2025

   · 

  5 min read
• Press Releases

  Neuronascent Announces Progress for Lead Candidate NNI-362: Publication of Phase 1a Clinical Trial Results and FDA Grants Waiver of Fee for Canine Cognitive Disorder 2025 Submissions

  August 13, 2025

   · 

  3 min read
• Press Releases

  Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update

  August 13, 2025

   · 

  9 min read
• Press Releases

  Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

  August 13, 2025

   · 

  12 min read